Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™
2024; Taylor & Francis; Volume: 21; Issue: 7 Linguagem: Inglês
10.1080/17434440.2024.2353722
ISSN1745-2422
AutoresPascal Frederiks, Gianluca Castaldi, Keir McCutcheon, Johan Bennett,
Tópico(s)Cerebrovascular and Carotid Artery Diseases
ResumoThe introduction of drug-eluting coronary stents (DES) into clinical practice in 2002 represented a major milestone in the treatment of obstructive coronary artery disease. Over the years, significant advances in polymer coating and in antiproliferative agent technology have further improved the safety and clinical performance of newer-generation DES.
Referência(s)